Critical Insights From BioNTech Analyst Ratings: What You Need To Know
Critical Insights From BioNTech Analyst Ratings: What You Need To Know
来自BioNTech分析师评级的关键见解：你需要知道的
Across the recent three months, 11 analysts have shared their insights on BioNTech (NASDAQ:BNTX), expressing a variety of opinions spanning from bullish to bearish.
在最近三个月中，11位分析师分享了他们对BioNTech（纳斯达克股票代码：BNTX）的见解，表达了从看涨到看跌的各种观点。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天中情绪的变化，并将其与前几个月进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $112.55, a high estimate of $171.00, and a low estimate of $90.00. This current average has increased by 1.79% from the previous average price target of $110.57.
分析师通过对12个月目标股价的评估提供了更深入的见解，显示平均目标价为112.55美元，最高估计为171.00美元，低估值为90.00美元。目前的平均价格较之前的平均目标价110.57美元上涨了1.79％。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析师评级：深度分析
In examining recent...
在研究...
登录免费看全文
登录/注册